Search Results - "Vaugier, L."

Low-energy models for correlated materials: bandwidth renormalization from Coulombic screening by Casula, M, Werner, Ph, Vaugier, L, Aryasetiawan, F, Miyake, T, Millis, A J, Biermann, S

“…We provide a prescription for constructing Hamiltonians representing the low-energy physics of correlated electron materials with dynamically screened Coulomb…”
Get full text

Long-range Coulomb interactions in surface systems: a first-principles description within self-consistently combined GW and dynamical mean-field theory by Hansmann, P, Ayral, T, Vaugier, L, Werner, P, Biermann, S

“…Systems of adatoms on semiconductor surfaces display competing ground states and exotic spectral properties typical of two-dimensional correlated electron…”
Get full text

First-line immunotherapy in non-small cell lung cancer diagnosed with brain metastases by Nigen, B, Bodergat, T, Vaugier, L, Pons-Tostivint, E

“…Up to 30% patients newly diagnosed with advanced non-small cell lung cancer (NSCLC) present with brain metastases. In the absence of oncogenic addiction,…”
Get more information

Radiation therapy in the thoracic region: Radio-induced cardiovascular disease, cardiac delineation and sparing, cardiac dose constraints, and cardiac implantable electronic devices by Petit, C., Escande, A., Sarrade, T., Vaugier, L., Kirova, Y., Tallet, A.

“…Radiation therapy in the thoracic region may deliver incidental ionizing radiation to the surrounding healthy structures, including the heart. Radio-induced…”
Get full text

Discontinuous stereotactic body radiotherapy schedule increases overall survival in early-stage non-small cell lung cancer by Duvergé, L., Bondiau, P.-Y., Claude, L., Supiot, S., Vaugier, L., Thillays, F., Doyen, J., Ricordel, C., Léna, H., Bellec, J., Chajon, E., de Crevoisier, R., Castelli, J.

“…•Aim: To evaluate the benefit of discontinuous SBRT schedule on local control (LC) and overall survival (OS) in NSCLC patients.•Results: OS and LC were…”
Get full text

Stereotactic body radiation therapy for adrenal gland metastases: A multi-institutional outcome analysis by Yuste, C., Passerat, V., Calais, G., Schipman, B., Vaugier, L., Paumier, A., Huertas, A., Hemery, CG, Debelleix, C., Chamois, J., Blanchard, N., Septans, AL, Pointreau, Y.

“…•We present the largest French, multicenter, retrospective study on oligometastatic patients treated with SBRT for an adrenal metastasis.•A total of 110…”
Get full text

The phenotype caused by recessive variations in SLC25A22: Report of a new case and literature review by André, M.-V., Cacciagli, P., Cano, A., Vaugier, L., Roussel, M., Girard, N., Chabrol, B., Villard, L., Milh, M.

“…We describe the clinical, electroencephalography (EEG), and developmental features of a patient with developmental and epileptic encephalopathy due to a…”
Get full text

Association between post-operative hPG80 (circulating progastrin) detectable level and worse prognosis in glioblastoma by Doucet, L., Cailleteau, A., Vaugier, L., Gourmelon, C., Bureau, M., Salaud, C., Roualdes, V., Samarut, E., Aumont, M., Zenatri, M., Loussouarn, D., Quillien, V., Bocquet, F., Payen-Gay, L., Joubert, D., Prieur, A., Robert, M., Frenel, J.-S.

“…Patients with glioblastomas have a dismal prognosis, and there is no circulating predictive or prognostic biomarker. Circulating progastrin, hPG80, is a…”
Get full text

Comment on "Zero-field Kondo Splitting and Quantum-Critical Transition in Double Quantum Dots" by Vaugier, L, Aligia, A A, Lobos, A M

Get full text

Neural networks underlying hyperkinetic seizures of “temporal lobe” origin by Vaugier, L, Aubert, S, McGonigal, A, Trébuchon, A, Guye, M, Gavaret, M, Regis, J, Chauvel, P, Wendling, F, Bartolomei, F

“…Summary Purpose Hyperkinetic seizures are most often considered to originate from prefrontal cortex. Recently however, it has been suggested that hyperkinetic…”
Get full text

MO-0554 Pelvic dose accumulation from time-successive prostate and lymph node radiation (NCT02274779) by Vaugier, L., Guimas, V., Chiavassa, S., Delpon, G., Supiot, S.

Get full text

PO-1527 REPAIR-GETUG P16: stereotactic reirradiation with metformin for relapse in irradiated prostate bed by guimas, V., Supiot, S., rio, E., chiavassa, S., blanc lapierre, A., schick, U., roge, M., vaugier, L., perennec, T.

Get full text

Réorganisation de la connectivité structurale dans les épilepsies temporales by Scarvada, D, Vaugier, L, Ranjeva, J.-P, Bettus, G, Confort-Gouny, S, Cozzone, P.-J, Chauvel, P, Bartolomei, F, Guye, M

Get full text

OC-0762 High-dose chemotherapy followed by whole lung irradiation in pulmonary relapse Ewing's sarcomas by Duvergé, L., Demoor-Goldschmidt, C., Laprie, A., Cervellera, M., Castex, M., Corradini, N., Supiot, S., Vaugier, L., Marec- Berard, P., Claude, L.

Get full text

OC-0434 Long -term results of OLIGOPELVIS, a Phase II Trial of pelvic RT in Oligorecurrent Prostate Cancer by Supiot, S., Vaugier, L., Pasquier, D., Buthaud, X., Magné, N., Peiffert, D., Sargos, P., Crehange, G., Pommier, P., Loos, G., Hasbini, A., Latorzeff, I., Silva, M., Denis, F., Lagrange, J., Morvan, C., Campion, L., Blanc-Lapierre, A., Paul, J.

Get full text

PH-0278: Schedule of irradiation impacts the overall survival in case of SBRT for stage I NSCLC by Duvergé, L., Bondiau, P., Claude, L., Thillays, F., Supiot, S., Sidibe, I., Vaugier, L., Bellec, J., Ricordel, C., Doyen, J., Chajon, E., De Crevoisier, R., Castelli, J.

Get full text

PV-0623: Toxicity and Quality of Life of Salvage Pelvic Irradiation of Prostatic Cancer Node Relapse by Vaugier, L., Palpacuer, C., Rio, E., Pacteau, V., Mauboussin, M.H., Campion, L., Pein, F., Supiot, S.

Get full text

Primitive cytokines and cytokine receptors in invertebrates: the sea star Asterias rubens as a model of study by Legac, E, Vaugier, G L, Bousquet, F, Bajelan, M, Leclerc, M

“…It has been previously demonstrated that the sea star axial organ is a primitive immune organ. Phagocytic, lymphoid-like cells have been characterized with…”
Get more information

OC-0210: Salvage radiotherapy in oligorecurrent pelvic node relapses of prostate cancer : a phase 2 trial by Supiot, S., Pasquier, D., Buthaud, X., Magne, N., Becckendorf, V., Crehange, G., Pommier, P., Loos, G., Hasbini, A., Latorzeff, I., Silva, M., Denis, F., Campion, L., Vaugier, L., Blanc-Lapierre, A.

Get full text

PH-0117: Radiotherapy of T4M0 prostate cancer : A multicentric retrospective analysis by Goupy, F., Meyer, E., Pommier, P., Magné, N., Sargos, P., Pasquier, D., Noël, G., Schick, U., Hasbini, A., Supiot, S., Bossi, A., Latorzeff, I., Riverain, J., Duvergé, L., Benna, M., Benziane, N., Le Roy, T., Bigot, C., Rehn, M., Vaugier, L., Le Proust, B., Barateau, A., Campillo-Gimenez, B., Castelli, J., De Crevoisier, R.

Get full text